Erratum to: Eur J Nucl Med Mol Imaging

DOI 10.1007/s00259-012-2298-2

Four of the six patients who were further investigated by biopsy were unfortunately misnumbered. The correct numbers are: 10, 16, 19, 21–23. All PSMA-positive lesions which were histologically investigated were confirmed as prostate cancer and metastases.

Patient no. 21 with an initial high Gleason Score (Table 1) had two lymph node metastases and one soft tissue metastasis (histologically confirmed). Therefore, amongst the selected 65 representative lesions (Fig. 5), 11 were defined as local relapses (nos. 1, 11, 12, 14, 15, 22, 23, 44, 54, 57, and 58), 24 as bone metastases (nos. 5–9, 18–20, 24, 30–34, 43, 50–53, 59, 61, 62, 64, and 65), 23 as lymph node metastases (nos. 2–4, 10, 16, 17, 21, 25–29, 35, 37, 39, 40, 42, 45–48, 60, and 63) and 7 as soft tissue metastases (nos. 13, 36, 38, 41, 49, 55, and 56).

Neither the results and the message of this study nor the measurements and values of the lesions listed in Fig. 5 are affected by this correction. The authors regret the errors and any inconvenience caused.